Pristiq And Approval
The U.S. Food and Drug Administration has approved Pristiq for the treatment of major depressive disorder in adults. Pristiq is drugmaker Wyeth's successor to Effexor XR, but unlike Effexor, Pristiq can be taken at a therapeutic dose immediately. Most antidepressants require patients to start at a lower dose and then gradually increase to the desired dose.
Read moreMore information on "Pristiq And Approval"
From Our Sources
FDA approves Pristiq for major depressive disorder
The U.S. Food and Drug Administration (FDA) has granted initial approval for Pristiq as a treatment for adults with major depressive disorder.... Read more »
Pristiq could join Effexor in treating hot flashes, depression...
Drugmaker Wyeth is seeking U.S. Food and Drug Administration approval for Pristiq to treat both major depression and hot flashes in women. But... Read more »
FDA will not delay Pristiq, maker says
Though the U.S. Food and Drug Administration (FDA) has asked for more information on Pristiq, its maker says this request will not delay the med's... Read more »
Pristiq Oral Precautions and Side Effects
Source: First DataBank
Generic Name: DESVENLAFAXINE SUSTAINED RELEASE - ORAL Pronounced: (des-VEN-la-FAX-een) Warning Antidepressant medications are used to treat a... Read more »
Zogenix receives approval for DosePro
Drugmaker Zogenix has been granted approval of the Sumavel DosePro--a system that delivers subcutaneous doses of sumatriptan without use of a needle.... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
